Thursday, 27 January 2022
  
Login

Australia's most trusted
source of pharma news

Thursday, 27 January 2022

Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (10)

Sales & Customer Relations (29)

Access & Reimbursement (1)

Clinical & Medical, R&D (16)

Regulatory, Pharmacovigilance & QA (6)

Other (17)

News

Generic chases down Novartis

Posted 20 December 2021 AM

It's been a slow week of TGA approvals with Beximco Pharmaceuticals the sole company to register a product, adding two new generic brande names for Novartis' OTC eye drops for conjuctivitis. 

The company which currently has six generic products of Novartis' medicine Zaditen on the market, registered its first copy back in 2018 under the brand name Tofen Eye Drops.

To see the whole article, please login

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.